July 2, 2025 · Form 4 insider transaction
Plesha Scott M. bought 83,678 shares of Pelthos Therapeutics Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 21 days after the transaction.
On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 83,678 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.